- Home
- KROS vs ITRN Comparison
KROS vs ITRN Comparison
Compare KROS & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- ITRN
- Stock Information
- Founded
- KROS 2015
- ITRN 1994
- Country
- KROS United States
- ITRN Israel
- Employees
- KROS N/A
- ITRN N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- ITRN Electronic Components
- Sector
- KROS Health Care
- ITRN Technology
- Exchange
- KROS Nasdaq
- ITRN Nasdaq
- Market Cap
- KROS 565.0M
- ITRN 810.3M
- IPO Year
- KROS 2020
- ITRN 2005
- Fundamental
- Price
- KROS $15.80
- ITRN $35.46
- Analyst Decision
- KROS Buy
- ITRN Buy
- Analyst Count
- KROS 14
- ITRN 1
- Target Price
- KROS $20.56
- ITRN $50.00
- AVG Volume (30 Days)
- KROS 417.9K
- ITRN 174.4K
- Earning Date
- KROS 11-05-2025
- ITRN 08-19-2025
- Dividend Yield
- KROS N/A
- ITRN 5.63%
- EPS Growth
- KROS N/A
- ITRN 9.57
- EPS
- KROS 0.47
- ITRN 2.79
- Revenue
- KROS $232,844,000.00
- ITRN $339,610,000.00
- Revenue This Year
- KROS $5,579.44
- ITRN $7.03
- Revenue Next Year
- KROS N/A
- ITRN $9.69
- P/E Ratio
- KROS $34.08
- ITRN $12.96
- Revenue Growth
- KROS 85820.30
- ITRN 3.30
- 52 Week Low
- KROS $9.12
- ITRN $25.87
- 52 Week High
- KROS $72.37
- ITRN $45.43
- Technical
- Relative Strength Index (RSI)
- KROS 60.69
- ITRN 46.17
- Support Level
- KROS $15.34
- ITRN $32.71
- Resistance Level
- KROS $15.85
- ITRN $36.19
- Average True Range (ATR)
- KROS 0.48
- ITRN 1.22
- MACD
- KROS -0.01
- ITRN 0.25
- Stochastic Oscillator
- KROS 78.71
- ITRN 66.95
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ITRN Ituran Location and Control Ltd.
Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.